Briefly noted: Y Ye et al. Gastroenterol 2022; 162: 109-121. Open Access: Epidemiology, Etiology, and Treatment of Gastroparesis: Real-World Evidence From a Large US National Claims Database
- The overall standardized prevalence of gastroparesis was 267.7 per 100,000 US adults, whereas prevalence of “definite” gastroparesis (individuals diagnosed within 3 months of gastric emptying scintigraphy testing with persistent symptoms for more than 3 months) was 21.5 per 100,000
- Etiology was most commonly due to diabetes (57.4%; type 1, 5.7% and type 2, 51.7%), followed by postsurgical (15.0%), drug-induced (11.8%), and idiopathic (11.3%) etiologies
Related blog posts:
- Are Gastroparesis and Functional Dyspepsia Part of the Same Problem?
- Provacative Study: Pyloric Botox for Feeding Difficulties Baseline gastric emptying results did not predict IPBI response
- Is a Gastric Emptying Study Helpful in Children?
- Trying to Understand Gastroparesis
- Gastric Electrical Stimulation For Refractory Vomiting, IBD Resources & MMWR COVID-19 Report | gutsandgrowth
- What to do with delayed gastric emptying/gastroparesis
- Pregabalin Helpful for Functional Dyspepsia in Small Study | gutsandgrowth
- A 6-Year Study of Amitriptyline, Escitalopram, and Functional Dyspepsia